<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Hepatitis A - Creating a Market for Another Superfluous Vaccine</title><link>http://articles.mercola.com/sites/articles/archive/2002/02/23/hepatitis-a-part-two.aspx</link><description>By Dr. Tim O'Shea Part 1 of 2 They finally did it. After years of lobbying and angling, GlaxoSmithKline finally got their new vaccine for Hepatitis A tacked onto the mandated schedule as of Jan 2002, with no public fanfare. ( www.aap.org ) The vaccine</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>